Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Study Number: 

I 32316

Phase: 
1
Trial categories: 
Melanoma
Immunotherapy
Antibody therapy
Checkpoint blockade
Early Phase Clinical Trial
Principal Investigator: